Clinical Trials Browser

Phase 1 × INDUSTRY × donafenib × Clear all

NCT04402723 2022-12-01

Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04472858 2022-11-29

A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumor